We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+11.08%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.22B
AUM Growth
+$24.1M
Cap. Flow
-$64.8M
Cap. Flow %
-5.33%
Top 10 Hldgs %
43.43%
Holding
146
New
4
Increased
19
Reduced
40
Closed
11

Top Buys

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$2.29M
2
MCHP icon
Microchip Technology
MCHP
+$2.24M
3
DIOD icon
Diodes
DIOD
+$1.56M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.49M
5
CNC icon
Centene
CNC
+$1.41M

Top Sells

Rank Stock Value
1
GD icon
General Dynamics
GD
+$20.3M
2
GNTX icon
Gentex
GNTX
+$7.84M
3
NVDA icon
NVIDIA
NVDA
+$4.77M
4
ORCL icon
Oracle
ORCL
+$4.76M
5
KLAC icon
KLA
KLAC
+$4.51M

Sector Composition

Rank Sector Weight
1 Technology 44.62%
2 Healthcare 17.06%
3 Communication Services 12.9%
4 Financials 11.14%
5 Consumer Discretionary 10.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
76
Medtronic
MDT
$110B
$2.24M 0.18%
27,825
+14,331
+106% +$1.17M
NDSN icon
77
Nordson
NDSN
$16.4B
$2.19M 0.18%
9,854
– –
UTHR icon
78
United Therapeutics
UTHR
$26.2B
$2.11M 0.17%
9,421
-1,585
-14% -$391K
JAZZ icon
79
Jazz Pharmaceuticals
JAZZ
$16.2B
$2.01M 0.17%
13,747
+10,092
+276% +$1.49M
MRNA icon
80
Moderna
MRNA
$23B
$2.01M 0.17%
13,081
– –
ILMN icon
81
Illumina
ILMN
$31B
$2M 0.16%
8,835
-1,976
-18% -$404K
UNH icon
82
UnitedHealth
UNH
$383B
$1.97M 0.16%
4,169
-3,081
-42% -$1.49M
ELV icon
83
Elevance Health
ELV
$81.6B
$1.93M 0.16%
4,187
-1,821
-30% -$867K
LRCX icon
84
Lam Research
LRCX
$372B
$1.86M 0.15%
35,000
– –
HUM icon
85
Humana
HUM
$44B
$1.81M 0.15%
3,730
– –
BIIB icon
86
Biogen
BIIB
$30.7B
$1.72M 0.14%
6,190
– –
JKHY icon
87
Jack Henry & Associates
JKHY
$11B
$1.64M 0.13%
10,875
-4,055
-27% -$677K
SAIC icon
88
Saic
SAIC
$4.89B
$1.61M 0.13%
14,972
– –
SYK icon
89
Stryker
SYK
$133B
$1.56M 0.13%
5,482
-3,402
-38% -$903K
UI icon
90
Ubiquiti
UI
$32.3B
$1.54M 0.13%
5,663
– –
FFIV icon
91
F5
FFIV
$22.1B
$1.53M 0.13%
10,525
– –
CTRA
92
DELISTED
Coterra Energy
CTRA
$1.51M 0.12%
61,541
– –
MOH icon
93
Molina Healthcare
MOH
$10.2B
$1.47M 0.12%
5,495
-13,491
-71% -$3.88M
JNJ icon
94
Johnson & Johnson
JNJ
$617B
$1.45M 0.12%
9,339
-3,669
-28% -$592K
PCTY icon
95
Paylocity
PCTY
$7.32B
$1.44M 0.12%
7,220
– –
FTNT icon
96
Fortinet
FTNT
$113B
$1.38M 0.11%
20,800
– –
CNC icon
97
Centene
CNC
$30.1B
$1.26M 0.1%
+19,900
New +$1.41M
VRNT
98
DELISTED
Verint Systems
VRNT
$1.23M 0.1%
32,993
– –
ABG icon
99
Asbury Automotive
ABG
$4.34B
$1.22M 0.1%
5,821
-2,159
-27% -$458K
TSLA icon
100
Tesla
TSLA
$1.22T
$1.21M 0.1%
5,817
– –
2 3
4
5 6

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Oak Associates held 146 positions worth $1.22B, up 2% from $1.19B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Oak Associates withdrew a net $64.8M in Q1 2023, closing 11 positions and reducing 40 holdings. Its most notable exit was General Dynamics, an estimated $20.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 42% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Oak Associates opened a new position in Bio-Rad Laboratories Class A worth $2.34M.

  • Oak Associates's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 4,890 shares worth $2.34M.
  • Oak Associates added most to Microchip Technology in Q1 2023, an estimated $2.24M increase.
  • Oak Associates's biggest Q1 2023 reduction was NVIDIA, cutting an estimated $4.77M.
  • Oak Associates fully exited General Dynamics in Q1 2023, selling an estimated $20.3M.
  • Oak Associates's ten largest holdings make up 43% of its $1.22B portfolio in Q1 2023.
  • Oak Associates opened 4 new positions and closed 11 in Q1 2023.
  • Oak Associates's portfolio value rose 2% quarter-over-quarter to $1.22B.

Based on Oak Associates's 13F filing for Q1 2023, filed 11 May 2023.